Journal of Otolaryngology and Ophthalmology of Shandong University ›› 2021, Vol. 35 ›› Issue (4): 70-75.doi: 10.6040/j.issn.1673-3770.0.2020.395
Previous Articles Next Articles
GAO Lang1,2, CHEN Hongmei1, BAI Ye1,3, QIN Xuejiao1
CLC Number:
[1] Haas L, Maryniuk M, Beck J, et al. National standards for diabetes self-management education and support[J]. Diabetes Care, 2012, 35(11): 2393-2401. doi:10.2337/dc12-1707. [2] Yan J, Peng DF, Jiang F, et al. Impaired pancreatic beta cell compensatory function is the main cause of type 2 diabetes in individuals with high genetic risk: a 9 year prospective cohort study in the Chinese population[J]. Diabetologia, 2016, 59(7): 1458-1462. doi:10.1007/s00125-016-3939-y. [3] Croxen R, Baarsma GS, Kuijpers RW, et al. Somatostatin in diabetic retinopathy[J]. Pediatric Endocrinology Reviews, 2004, 1(Suppl 3):518-524 [4] 徐芬娟, 沈飞霞. 血糖波动的研究进展[J]. 中国糖尿病杂志, 2014, 22(9): 852-855. doi:10.3969/j.issn.1006-6187.2014.09.024. XU Fenjuan, SHEN Feixia. Research progress of blood glucose fluctuation[J]. Chin J Diabetes, 2014, 22(9): 852-855. doi:10.3969/j.issn.1006-6187.2014.09.024. [5] Rodbard D. Glucose variability: a review of clinical applications and research developments[J]. Diabetes Technol Ther, 2018, 20(S2): S25-S215. doi:10.1089/dia.2018.0092. [6] Danne T, Nimri R, Battelino T, et al. International consensus on use of continuous glucose monitoring[J]. Diabetes Care, 2017, 40(12): 1631-1640. doi:10.2337/dc17-1600. [7] Kan K, Zhu W, Lu F, et al. Contribution of structured self-monitoring of blood glucose to the glycemic control and the quality of life in both insulin- and noninsulin-treated patients with poorly controlled diabetes[J]. Diabetes Technology & Therapeutics, 2017, 19(12):707-714. doi:10.1089/dia.2017.0275. [8] Skrha J, Soupal J, Skrha J, et al. Glucose variability, HbA1c and microvascular complications[J]. Reviews in Endocrine & Metabolic Disorders, 2016, 17(1):103-110. doi:10.1007/s11154-016-9347-2. [9] 宋琛. 手术学全集眼科卷[M]. 北京: 人民军医出版社,1994. [10] Moghissi ES, Korytkowski MT, DiNardo M, et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control[J]. Diabetes Care, 2009, 32(6): 1119-1131. doi:10.2337/dc09-9029. [11] Ng MC, Cockburn BN, Lindner TH, et al. Molecular genetics of diabetes mellitus in Chinese subjects: identification of mutations in glucokinase and hepatocyte nuclear factor-1alpha genes in patients with early-onset type 2 diabetes mellitus/MODY[J]. Diabetic Medicine, 1999,16(11):956-963. doi:10.1046/j.1464-5491.1999.00188.x. [12] Ji L, Su Q, Feng B, et al. Structured self-monitoring of blood glucose regimens improve glycemic control in poorly controlled Chinese patients on insulin therapy: Results from COMPASS[J]. Journal of Diabetes, 2017,9(5):495-501. doi:10.1111/1753-0407.12434. [13] Ceriello A, Colagiuri S. International Diabetes Federation guideline for management of postmeal glucose: a review of recommendations[J]. Diabet Med, 2008, 25(10): 1151-1156. doi:10.1111/j.1464-5491.2008.02565.x. [14] Kato A, Tatsumi Y, Yako H, et al. Recurrent short-term hypoglycemia and hyperglycemia induce apoptosis and oxidative stress via the ER stress response in immortalized adult mouse Schwann(IMS32)cells[J]. Neuroscience Research, 2019,147:26-32. doi:10.1016/j.neures.2018.11.004. [15] Su G, Mi SH, Tao H, et al. Impact of admission glycemic variability, glucose, and glycosylated hemoglobin on major adverse cardiac events after acute myocardial infarction[J]. Diabetes Care, 2013, 36(4): 1026-1032. doi:10.2337/dc12-0925. [16] Picconi F, Parravano M, Sciarretta F, et al. Activation of retinal Muller cells in response to glucose variability[J]. Endocrine, 2019,65(3):542-549. doi:10.1007/s12020-019-02017-5. [17] Riddle MC. Effects of intensive glucose lowering in the management of patients with type 2 diabetes mellitus in the Action to Control Cardiovascular Risk in Diabetes(ACCORD)trial[J]. Circulation, 2010, 122(8): 844-846. doi:10.1161/CIRCULATIONAHA.110.960138. [18] 姚晶磊, 肖林, 徐冰, 等. 糖尿病患者白内障围手术期血糖波动及预后的研究进展[J]. 国际眼科杂志, 2008, 8(2): 348-350. YAO Jinglei, XIAO Lin, XU Bing, et al. Blood sugar fluctuation and prognosis of diabetic patients in perioperative period of cataract surgery[J]. Int J Ophthalmol, 2008, 8(2): 348-350. [19] Mechanick JI, Youdim A, Jones DB, et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient-2013 update: cosponsored by American Association of Clinical Endocrinologists[J]. The Obesity Society, and American Society for Metabolic & Bariatric Surgery, 2013, 21(Suppl 1):S1-S27. doi:10.1002/oby.20461. [20] Evans CH, Lee J, Ruhlman MK. Optimal glucose management in the perioperative period[J]. Surg Clin North Am, 2015, 95(2): 337-354. doi:10.1016/j.suc.2014.11.003. [21] 薛春丽. 糖尿病视网膜病变患者白内障手术前后散瞳直径的对比研究[J]. 医药论坛杂志, 2011, 32(8): 192-193. [22] Xu JY, Dan QH, Chan V, et al. Genetic and clinical characteristics of maturity-onset diabetes of the young in Chinese patients[J]. European Journal of Human Genetics: EJHG, 2005,13(4):422-427. doi:10.1038/sj.ejhg.5201347. |
No related articles found! |
|